Nottingham University Hospitals

What Nottingham University Hospitals does

Nottingham University Hospitals NHS Trust (NUH) is one of the largest and busiest NHS Trusts in England, operating as a publicly funded statutory body within the UK National Health Service. With approximately 20,000 colleagues across more than 350 career types, NUH runs two main acute hospital sites — Queen's Medical Centre (QMC) and City Hospital — alongside Nottingham Children's Hospital, Ropewalk House, and the National Rehabilitation Centre (opening 2025). The Trust directly serves more than 2.5 million residents of Nottingham and Nottinghamshire and a further four million people across the East Midlands, with QMC's Emergency Department treating over 600 patients per day and acting as the region's designated Major Trauma Centre. Service lines span emergency and acute medicine, cancer care (including radiotherapy and the Nottingham Breast Institute), maternity, children's health, cardiology, respiratory, gastroenterology, cystic fibrosis, palliative care (Hayward House), and tertiary/quaternary specialist services.

Research and innovation are central to NUH's operating model. The Trust hosts the NIHR Nottingham Biomedical Research Centre (in partnership with the University of Nottingham and Nottinghamshire Healthcare NHS Foundation Trust), the NIHR Nottingham Clinical Research Facility, and — from April 2024 — the NIHR HealthTech Research Centre for Rehabilitation. It leads the East Midlands Secure Data Environment, is a founding member of the HDRUK Alliance, and contributes to the BREATHE respiratory data hub. NUH runs 188 commercial research partnerships with organisations including AstraZeneca, Orion Pharma, Parexel, and Quotient Sciences, and operates the Pathogen Bank (~3,500 isolates), Nottingham Genomics Laboratory Service, CHEATA med-tech adoption support, and DREEAM / the Institute of Care Excellence for education and training.

NUH's revenue model is dominated by NHS England block-contract commissioning for publicly delivered, free-at-the-point-of-use services, supplemented by NIHR research grants, commercial trial income, charitable income through Nottingham Hospitals Charity (£4.2m voluntary income, £3.68m granted), and minor fees from media filming (notably Channel 4's BAFTA-nominated '24 Hours in A&E' documentary at QMC). The Trust is overseen by a Board accountable to NHS England and Parliament, is regulated by the CQC (current overall rating 'Requires Improvement', 13 September 2023) and the MHRA (subject to a March 2024 GCP inspection and ongoing CAPA programme), and is a founding partner of the UK National Rehabilitation Centre programme.

Name

Nottingham University Hospitals

Legal name

Nottingham University Hospitals NHS Trust

Website

https://nuh.nhs.uk

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Nottingham University Hospitals NHS Trust is a publicly funded NHS Trust operating Queen's Medical Centre, City Hospital, Nottingham Children's Hospital, and Ropewalk House in Nottingham, delivering acute, emergency, specialist, and research-enabled healthcare to 2.5 million residents and a wider East Midlands population of 4 million.

Ownership category

akta.pro rank

Product category

Acute Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Acute hospital services
• NHS specialist care
• Clinical research services
• Cancer treatment services
• Rehabilitation healthcare

Headquarters

HQ city

Nottingham

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. NHS Core Funding: As an NHS Trust, Nottingham University Hospitals receives core funding from the UK National Health Service for providing hospital and healthcare services to the public. This constitutes the primary revenue stream for all operational activities.
2. Research Grants and Funding: NUH receives research funding from the National Institute for Health and Care Research (NIHR) and other grant-making bodies for clinical research activities. The Trust also partners with industry through 188 commercial partnerships.
3. Nottingham Hospitals Charity Donations: Voluntary charitable income from donations, fundraising events, corporate partnerships, community fundraising, and legacy gifts. Total voluntary income was £4.2 million with £3.68 million granted.
4. Filming Location Fees: NUH earns revenue from film and TV productions filming on hospital premises. Fees are agreed case-by-case covering administration, staff support and facilities use. All income is reinvested into NUH.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Nottingham University Hospitals NHS Trust operates multiple hospital sites providing a comprehensive range of acute, specialist, and tertiary healthcare services to patients across Nottingham, Nottinghamshire, and the East Midlands. Alongside patient care, NUH runs a major clinical research portfolio through NIHR-funded facilities and commercial/academic partnerships, supporting clinical trials, translational research, and experimental medicine.

Product overview

Nottingham University Hospitals NHS Trust (NUH) is one of the largest and busiest NHS Trusts in the UK, operating Queen's Medical Centre (QMC) and City Hospital as its two main hospital sites, alongside Nottingham Children's Hospital, Ropewalk House, and the forthcoming National Rehabilitation Centre (NRC, opening 2025). The trust delivers a broad portfolio of specialist clinical services spanning emergency and major trauma care, maternity, cancer (radiotherapy, systemic therapies, specialist units), cardiovascular (cardiac centre), respiratory, neurology, gastroenterology, Cystic Fibrosis, breast care, palliative care (Hayward House), and rehabilitation. Research and innovation are central to NUH's mission, embedded through the NIHR Nottingham Biomedical Research Centre (BRC), NIHR Nottingham Clinical Research Facility (CRF), NIHR HealthTech Research Centre for Rehabilitation, the Nottingham Genomics Laboratory Service (NGLS), Medical Physics and Clinical Engineering (including CHEATA for med-tech adoption), and the Pathogen Bank. The trust also runs education and training infrastructure including DREEAM, the NUH Simulation Hub, and the Institute of Care Excellence (ICE). Digital patient tools include Badger Notes/BadgerNet for maternity records. NUH's charitable partner, Nottingham Hospitals Charity, funds appeals including the Big Appeal for Nottingham Children's Hospital and Hayward House palliative care. The trust is a location partner for media productions including Channel 4's BAFTA-nominated 24 Hours in A&E documentary series.

Differentiator

Problem solved

Functional benefit

Products and services

• Emergency and Major Trauma Care 24/7 A&E and major trauma services at Queen's Medical Centre, serving the East Midlands as a designated major trauma centre.
• Cancer Treatment Services Specialist oncology services including chemotherapy, radiotherapy, and surgical oncology for patients across the East Midlands.
• Cardiac and Cardiothoracic Services Specialist heart and lung services including cardiac surgery, interventional cardiology, and thoracic surgery.
• Neuroscience Services Neurology and neurosurgery services for patients with brain, spinal, and neurological conditions.
• Renal Services Specialist renal medicine and dialysis services for patients with kidney disease.
• Children's and Paediatric Services Specialist paediatric care including the Nottingham Children's Hospital, covering emergency, surgical, and inpatient paediatric care.
• Maternity and Neonatal Services Maternity services including the Nottingham University Hospital maternity unit and neonatal intensive care.
• Rehabilitation Services Specialist rehabilitation services delivered through the National Rehabilitation Centre, providing intensive rehabilitation for patients with complex neurological, musculoskeletal, and trauma-related conditions.
• Clinical Research Services Commercial clinical research services for pharmaceutical, biotech, medical device, and academic partners, including clinical trial delivery, translational research, and experimental medicine studies.
• Outpatient and Diagnostic Services Outpatient consultations, diagnostic imaging, pathology, and day-case procedures delivered across multiple hospital sites.

Quantifiable outcome

• Over 600 patients treated in the Emergency Department every day at QMC
• +4 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature8 records

Partnerships

19 partnerships are on record, tiered core and flagship.

• AstraZenecacoreTechnology or IntegrationOne of 188 commercial partnerships NUH works through with industry-leading organisations. AstraZeneca participates in clinical trials and research collaborations at NUH as part of the Trust's commercial research programme.
• Orion PharmacoreTechnology or IntegrationOne of 188 commercial partnerships. Orion Pharma works with NUH on clinical research and drug development activities.
• ParexelcoreTechnology or IntegrationA global CRO (Contract Research Organisation) partner supporting clinical trial operations at NUH as part of the 188 commercial partnerships.
• Quotient SciencescoreTechnology or IntegrationA pharmaceutical development company partner working with NUH on clinical research as part of the 188 commercial partnerships.
• Medilink East MidlandscoreStrategic or Co-development PartnerDelivers the INSTILS (Inspiring Networking to Stimulate Technology Innovation in Life Sciences) programme in partnership with NUH, part-funded by ERDF, supporting SMEs to develop innovative healthcare products. INSTILS total project cost £7,393,742 with ERDF value £3,696,871, running until September 2021, covering the D2N2 LEP area.
• East Midlands Academic Health Science Network (EMAHSN)coreStrategic or Co-development PartnerStrategic partner in the INSTILS programme supporting life sciences innovation in the East Midlands, working with NUH and other partners.
• University of NottinghamflagshipStrategic or Co-development PartnerPrimary academic partner of NUH in the NIHR Nottingham Biomedical Research Centre and NIHR Nottingham Clinical Research Facility. Supports translational research, clinical trials, education, and training. The partnership drives world-class clinical research translating scientific discoveries into NHS practice.
• Nottinghamshire Healthcare NHS Foundation TrustcoreStrategic or Co-development PartnerPartner in the NIHR Nottingham Biomedical Research Centre supporting integration of clinical research across the regional NHS system.
• National Institute for Health and Care Research (NIHR)flagshipStrategic or Co-development PartnerPrincipal funder and regulatory body for clinical research at NUH. NIHR supports the Nottingham Biomedical Research Centre, Clinical Research Facility, HealthTech Research Centre for Rehabilitation, and all NIHR performance reporting.
• Health Data Research UK (HDRUK) AlliancecoreStrategic or Co-development PartnerNUH was one of the first NHS hospitals to join the HDRUK Alliance (February 2019), which accelerates progress in medicine and health through better access to health data across 10 founding members.
• BREATHE - Health Data Research Hub for Respiratory HealthcoreStrategic or Co-development PartnerNUH researchers are part of the national BREATHE Hub (launched September 2019) working across the UK with patients, charities, universities, industry and the NHS to use health data to find new treatments for respiratory conditions including asthma and COPD.
• Loughborough UniversitycoreStrategic or Co-development PartnerAcademic partner in the NIHR HealthTech Research Centre for Rehabilitation alongside NUH, University of Nottingham, and Nottingham Trent University.
• Nottingham Trent UniversitycoreStrategic or Co-development PartnerAcademic partner in the NIHR HealthTech Research Centre for Rehabilitation, contributing expertise to rehabilitation technology research.
• Defence Medical Rehabilitation Centre (DMRC)coreStrategic or Co-development PartnerDMRC at Stanford Hall (opened 2018) is co-located with the National Rehabilitation Centre being built by NUH. Both facilities share expertise and infrastructure for rehabilitation research and clinical practice.
• National Rehabilitation Centre (NRC)flagshipStrategic or Co-development PartnerA 70-bed purpose-built NHS rehabilitation facility being built as part of the Government's New Hospital Programme at Stanford Hall near Loughborough, due to open in 2025. Research is integral to the NRC's design with clinical and academic partners developing world-leading rehabilitation research projects.
• NuVisioncoreTechnology or IntegrationNuVision is the commercial partner taking the Nu-Vision® amniotic sac tissue product to market. The product was developed through a unique collaboration between patients, researchers, scientists, industry and regulators, creating an improved patient pathway for ophthalmology patients.
• NIHR Nottingham Biomedical Research Centre (BRC)flagshipStrategic or Co-development PartnerPartnership between NUH and University of Nottingham, supported by Nottinghamshire Healthcare NHS Foundation Trust. Translates new scientific discoveries into new medicines, therapies and technology for NHS use. Focus areas include respiratory, hearing, musculoskeletal, GI/liver, dementia, ophthalmology, children's health, and cancer.
• NIHR Nottingham Clinical Research Facility (CRF)flagshipStrategic or Co-development PartnerNUH-hosted CRF supporting the delivery and development of experimental medicine research, the first step towards developing new treatments for use in the NHS.
• Nottingham Hospitals CharitycoreStrategic or Co-development PartnerCharitable arm of NUH raising voluntary funds (£4.2 million income, £3.68 million granted) for patient care improvements, research, equipment, and facilities across Nottingham's NHS hospitals including the Robin Centre and Hayward House appeals.

Scale indicators14 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Guy's and St Thomas' NHS Foundation Trust: Large London NHS foundation teaching trust with strong biomedical research base and major trauma; broader portfolio than NUH but operates in the same NHS teaching-trust peer set.
• Imperial College Healthcare NHS Trust: London-based academic health science centre with NIHR BRC/CRF and close Imperial College partnership; comparable on translational research intensity and teaching-hospital model.
• King's College Hospital NHS Foundation Trust: Major London teaching hospital with tertiary/quaternary specialism (neurosciences, liver, cardiac) and an active research portfolio; comparable on major teaching-hospital scale and commercial research.
• Barts Health NHS Trust: Largest NHS trust in England by turnover; multi-site London teaching trust with major trauma, research and large workforce — peer on absolute size and operational complexity rather than direct geography.
• University College London Hospitals NHS Foundation Trust: London-based research-intensive NHS foundation trust co-located with UCL; comparable on academic partnership, NIHR infrastructure, and breadth of specialist services.

Direct peers

• Sheffield Teaching Hospitals NHS Foundation Trust: Large Yorkshire-region NHS teaching hospital trust of broadly comparable scale (~20,000 staff, multi-site, major trauma centre, full portfolio of acute and specialist services). Closest geographic and structural analogue to NUH among non-London English teaching trusts.
• University Hospitals of Leicester NHS Trust: Immediate East Midlands NHS teaching trust neighbour operating the Leicester Royal Infirmary and Glenfield; comparable scale, similar multi-site acute/teaching model, and overlapping regional referral catchment.
• Manchester University NHS Foundation Trust: Very large multi-site NHS teaching trust formed by merger; comparable breadth of specialist services, major trauma, research infrastructure and commercial research activity.
• University Hospitals Birmingham NHS Foundation Trust: One of the largest NHS teaching trusts in England; multi-site, major trauma centre, strong research and commercial partnerships portfolio. Closest analogue by absolute scale and research intensity.
• Oxford University Hospitals NHS Foundation Trust: Major research-intensive NHS teaching trust with close university partnership (University of Oxford), NIHR BRC/CRF hosting, and significant commercial clinical trials activity. Comparable on the research-intensive teaching hospital dimension.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nottmhospitals
• Facebookfacebook.com/nottinghamhospitals
• LinkedInlinkedin.com/company/nottinghamuniversityhospitalsnhstrust
• Instagraminstagram.com/nottmhospitals

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nottingham University Hospitals